Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation. (Q46461408)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

main subject

chronic myeloid leukemia

0 references

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Lange T

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Bumm T

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Mueller M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Otto S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Grommisch L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Musiol S

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Franke C

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Krahl R

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Niederwieser D

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Deininger MW

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1262-1265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15858618%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403752

11 January 2020

exact match

0 references

cites work

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403752

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403752

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403752

Molecular response to imatinib in late chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403752

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403752

21 January 2018

Identifiers

DOI

10.1038/SJ.LEU.2403752

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/raa6tpju2nfrrl7knk6nb4xvem

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_raa6tpju2nfrrl7knk6nb4xvem

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/raa6tpju2nfrrl7knk6nb4xvem

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/raa6tpju2nfrrl7knk6nb4xvem